Max Health stock costs INR 865.95 on October 12, 2026 at 58.1 P/ E

Published on 10/12/2026 at 13:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2026 revenue hit INR 85.36 billion, up 18.80 percent. Max Health stock traded at INR 865.95 on October 12, 2026, 1.40 percent above INR 854.00.

Key points in brief

Max Health stock was last at INR 865.95 on October 12, 2026, on the NSE.
The price stood 29.13 percent below the INR 1,221.90 52-week high and 1.40 percent above the INR 854.00 low.
Fiscal 2026 revenue reached INR 85.36 billion, while net profit was INR 14.42 billion.
The next quarterly results are scheduled for November 6, 2026.

Max Health, INE027H01010, Illustration mit AI erstellt.

Max Health (INE027H01010) was last at INR 865.95 on the NSE on October 12, 2026, at 3:29 p.m. IST, with the exchange marked closed. The price sat 29.13 percent below the INR 1,221.90 52-week high and 1.40 percent above the INR 854.00 low.

Price sits near yearly low

The current valuation places Max Health at a P/E ratio of 58.1 and a market capitalization of INR 842.8 billion. The share price is only INR 11.95 above its yearly low, leaving the distance to the lower end of the annual range materially smaller than the gap to the high.

Max Healthcare describes a network of 21 healthcare facilities with more than 6,100 beds across several Indian states, alongside homecare and pathology businesses. The company says about 85 percent of its bed capacity is in metro and tier-one cities.

Fiscal 2026 earnings base

Univest reported that fiscal 2026 revenue reached INR 85.36 billion, up 18.80 percent from fiscal 2025, while net profit rose 34.10 percent to INR 14.42 billion. Diluted earnings per share increased to INR 14.76 from INR 11.01.

The figures show that profit expanded faster than revenue during fiscal 2026, but the current P/E still leaves the valuation sensitive to the next earnings update. That makes the November reporting date a concrete calendar marker for the market.

Comparison with peers

Max Health: P/E 58.1, market capitalization INR 842.8 billion
Apollo Hospitals (NSE, INR): P/E 53.5, market capitalization INR 1,117.9 billion
Fortis Healthcare (NSE, INR): P/E 54.6, market capitalization INR 571.7 billion

Next results date is November 6

TickerLandia lists the next quarterly results for November 6, 2026. Its company page identifies Max Healthcare Institute as MAXHEALTH on the NSE and associates the listing with ISIN INE027H01010.

For market positioning, the main measurable tension is the gap between the current INR 865.95 price and the INR 1,221.90 yearly high, alongside a P/E of 58.1. The next results will test whether the fiscal 2026 earnings growth rate can support that valuation.